The Massey Cancer Center will continue the research programs that currently exist with some possible modifications. We are also exploring whether there is a critical mass of funded investigators that are active in the area of """"""""Carcinogenesis,"""""""" with the possibility that a new basic research program area may be formed involving some newly recruited faculty members to Centers program as well as new arrivals to our institution. The major thrust for new development for the next grant year is in the broad discipline of """"""""Immunology."""""""" This will involve an active recruitment of a faculty member in """"""""Tumor Immunology,"""""""" (using Developmental Funds) to complement the core of investigators in this area that are currently active and quite productive. Moreover, the basic research in immunology will contribute to and be enhanced by the planned recruitment of a clinical bone marrow transplantation scientist-clinician. This individual will lead the development of this clinical service activity for both pediatric and adult patients needs, as well as the clinical research related to it. Due to the completion of our clinical facility development project for both in-patient and out-patient areas expected in the spring of 1986, we will have new and expanded space for the Joint Cancer Clinic, as well as for the Medical-Surgical Oncology in-patient unit. The latter space will include new laminar flow rooms to be devoted to the development of the bone marrow transplantation program. Influential members of our Virginia community have become involved in a private fund raising plan for the financial support for this ambitious new program. The Cancer Education Program has been expanded in our center to include nursing oncology education as well as the medical and dental programs that have been on-going for many years. This program has a heavy emphasis on cancer research by the students of these schools and will draw upon and contribute to the established research programs of the Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-11
Application #
3101535
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1978-12-01
Project End
1987-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
11
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Porter-Stransky, Kirsten A; Centanni, Samuel W; Karne, Saumya L et al. (2018) Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal. Biol Psychiatry :
Nulton, Tara J; Kim, Nak-Kyeong; DiNardo, Laurence J et al. (2018) Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52-55
Sonnenschein, Halie A; Lawrence, Kenneth F; Wittenberg, Karli A et al. (2018) Suppressor of IKKepsilon forms direct interactions with cytoskeletal proteins, tubulin and ?-actinin, linking innate immunity to the cytoskeleton. FEBS Open Bio 8:1064-1082
Cobb, Caroline O; Soule, Eric K; Rudy, Alyssa K et al. (2018) Patterns and Correlates of Tobacco and Cannabis co-use by Tobacco Product Type: Findings from the Virginia Youth Survey. Subst Use Misuse 53:2310-2319
Radwa?ska, Malwina J; Jaskó?owski, Mateusz; Davydova, Elena et al. (2018) The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab. Acta Crystallogr D Struct Biol 74:681-689
Curry, Zachary A; Wilkerson, Jenny L; Bagdas, Deniz et al. (2018) Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 366:169-183
Ginder, Gordon D; Williams Jr, David C (2018) Readers of DNA methylation, the MBD family as potential therapeutic targets. Pharmacol Ther 184:98-111
Lancina 3rd, Michael G; Wang, Juan; Williamson, Geoffrey S et al. (2018) DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment. Mol Pharm 15:2883-2889
Vascak, Michal; Jin, Xiaotao; Jacobs, Kimberle M et al. (2018) Mild Traumatic Brain Injury Induces Structural and Functional Disconnection of Local Neocortical Inhibitory Networks via Parvalbumin Interneuron Diffuse Axonal Injury. Cereb Cortex 28:1625-1644
Chernoukhov, A; Hussein, A; Nkurunziza, S et al. (2018) Bayesian inference in time-varying additive hazards models with applications to disease mapping. Environmetrics 29:

Showing the most recent 10 out of 586 publications